Example: dental hygienist
IRIS guide for applicants - Europa
6 the organisation) for all IRIS submissions, RPIs and regulatory entitlements. This simplifies your management of submissions in IRIS. 5. “Choose Submission Type” is now coloured blue and 3 mandatory fields (marked with a red asterisk “*”) appear labelled “Organisation” “Location” and “Submission Type” (the first two only if you are applying on behalf of an organisation).
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
UITVOERINGSREGELS - UWV
www.uwv.nleen nieuwe versie van de Uitvoeringsregels (september 2020) die de versie van oktober 2019 vervangt. De gewijzigde regelgeving en de nadere toelichting zijn …
MODEL KWALITEITSSTATUUT GGZ - Zorginzicht
www.zorginzicht.nlMODEL KWALITEITSSTATUUT GGZ 1 januari 2020 versie 2.0 OVERZICHT WIJZIGINGEN: Recht om ingezet te worden als regiebehandelaar Behandelaren die voldoen aan gestelde eisen om regiebehandelaar te zijn, hebben het recht om ook
BACK TO THE FUTURE Written by Robert Zemeckis & Bob Gale
www.dailyscript.comA time and temperature clock on the BANK reads 3:43. MARTY skateboards down the business street and across traffic, narrowly missing being hit by a car! INT. YMCA — STAGE — DAY 3 MEMBERS of the PINHEADS rock band, KEYBOARDS, BASS and DRUMS, exchange nervous glances, repeatedly checking their watches. They*re all set up on stage.
EudraCT & EU CTR Frequently asked questions
eudract.ema.europa.eustatus (see question 3. ). The entire process of registration of a clinical trial in the database and of updating of its information is described in the page Registering a trial and updating its information. The steps required in order to post results are described in the Tutorials on posting results.
Praktijkkaart Neus-maagsonde bij volwassenen - MDL
www.mdl.nl3 visuele inspectie (zie kader); Bij afwijkingen is er mogelijk sprake van dislocatie. 3. Bij latere aanwijzingen van mogelijke dislocatie, d.m.v. pH-meting van aspiraat (zie kader) dat via de sonde is opgetrokken: • Bij klinische verschijnselen (benauwdheid, blauwverkleuring van de huid, hoesten, pijn, ernstig ongemak, zweten, angst).